DSW (DSW) was downgraded to sell from neutral at Goldman Sachs. The valuation isn't as attractive, as the stock trades at a premium to its peers and has limited growth potential, Goldman said.
Linear Technology (LLTC) was downgraded to underperform at Bank of America/Merrill Lynch. The valuation isn't as attractive, based on a $44 price target, analysts said.
Team Health (TMH) was downgraded to hold from buy at Jefferies. $49 price target. The company has limited earnings upside potential, Jefferies said.
United Technologies (UTX - Get Report) was upgraded to outperform from sector perform at RBC Capital Markets. $109 price target. The company is in play following word of interest from Honeywell (HON - Get Report) , RBC said.
Valeant Pharmaceuticals (VRX) was downgraded to sector perform from outperform at RBC Capital Markets. $85 price target. Visibility is limited following disclosure of the SEC probe, RBC said.